Borneo International Festival of Arts (BIFA): Rejuvenating a City through an Art Festival
International Journal of Business Events and Legacies · 21.05.2025 · 3 (2) · 56-67
DOI: 10.63007/alij1047 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Business Events and Legacies, online erschienen am 21.05.2025. Verfasst von Suwapa Jitman. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
The article delves into the transformative role of the 3-day inaugural Borneo International Festival of Arts (BIFA) held in July 2024 in Miri, Sarawak. As an industry-focused case study, this article showcases how BIFA transcended its role as an art festival to become a catalyst for cultural preservation, community engagement, and sustainable development. The event aligns with Sarawak’s Post-COVID Development Strategy 2030 (PCDS 2030) and the UN Sustainable Development Goals (SDGs), offering valuable insights for practitioners in cultural event planning and community revitalization. Featuring diverse activities such as traditional and contemporary art exhibitions, artisan markets, digital showcases, and environmental workshops, BIFA serves as a replicable model for cities seeking innovative approaches to economic and social rejuvenation.
Zitieren
APA
Jitman, S. (2025). Borneo International Festival of Arts (BIFA): Rejuvenating a City through an Art Festival. International Journal of Business Events and Legacies, 3(2), 56-67. https://doi.org/10.63007/alij1047
Vancouver
Jitman S. Borneo International Festival of Arts (BIFA): Rejuvenating a City through an Art Festival. International Journal of Business Events and Legacies. 2025;3(2):56-67. doi:10.63007/alij1047
BibTeX
@article{Jitman2025,
author = {Jitman, Suwapa},
title = {Borneo International Festival of Arts (BIFA): Rejuvenating a City through an Art Festival},
journal = {International Journal of Business Events and Legacies},
year = {2025},
volume = {3},
number = {2},
pages = {56--67},
doi = {10.63007/alij1047}
}
EUVIMED